ELIOR GROUP (ELIOR.PA)

FR0011950732 - Common Stock

2.734  +0.05 (+1.79%)

Fundamental Rating

3

Taking everything into account, ELIOR scores 3 out of 10 in our fundamental rating. ELIOR was compared to 56 industry peers in the Hotels, Restaurants & Leisure industry. ELIOR has a bad profitability rating. Also its financial health evaluation is rather negative. ELIOR has a decent growth rate and is not valued too expensively.



1

1. Profitability

1.1 Basic Checks

ELIOR had negative earnings in the past year.
ELIOR had a positive operating cash flow in the past year.
In the past 5 years ELIOR reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ELIOR reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -1.81%, ELIOR is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
The Return On Equity of ELIOR (-8.34%) is worse than 60.00% of its industry peers.
With a Return On Invested Capital value of 3.11%, ELIOR is not doing good in the industry: 66.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.81%
ROE -8.34%
ROIC 3.11%
ROA(3y)-6.07%
ROA(5y)-4.91%
ROE(3y)-25.24%
ROE(5y)-20.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.55%, ELIOR is doing worse than 76.00% of the companies in the same industry.
ELIOR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 70.72%, ELIOR is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ELIOR has remained more or less at the same level.
Industry RankSector Rank
OM 1.55%
PM (TTM) N/A
GM 70.72%
OM growth 3YN/A
OM growth 5Y-24.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.05%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELIOR is destroying value.
ELIOR has more shares outstanding than it did 1 year ago.
ELIOR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ELIOR has an improved debt to assets ratio.

2.2 Solvency

ELIOR has an Altman-Z score of 1.61. This is a bad value and indicates that ELIOR is not financially healthy and even has some risk of bankruptcy.
ELIOR's Altman-Z score of 1.61 is in line compared to the rest of the industry. ELIOR outperforms 52.00% of its industry peers.
The Debt to FCF ratio of ELIOR is 11.04, which is on the high side as it means it would take ELIOR, 11.04 years of fcf income to pay off all of its debts.
ELIOR has a Debt to FCF ratio of 11.04. This is in the lower half of the industry: ELIOR underperforms 64.00% of its industry peers.
ELIOR has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.37, ELIOR is in line with its industry, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 11.04
Altman-Z 1.61
ROIC/WACC0.52
WACC6.01%

2.3 Liquidity

ELIOR has a Current Ratio of 0.72. This is a bad value and indicates that ELIOR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.72, ELIOR is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.66 indicates that ELIOR may have some problems paying its short term obligations.
ELIOR's Quick ratio of 0.66 is on the low side compared to the rest of the industry. ELIOR is outperformed by 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.66

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.20% over the past year.
The Revenue has grown by 25.12% in the past year. This is a very strong growth!
Measured over the past years, ELIOR shows a small growth in Revenue. The Revenue has been growing by 1.34% on average per year.
EPS 1Y (TTM)74.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.14%
Revenue 1Y (TTM)25.12%
Revenue growth 3Y9.6%
Revenue growth 5Y1.34%
Sales Q2Q%26.03%

3.2 Future

The Earnings Per Share is expected to grow by 41.31% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.22% on average over the next years.
EPS Next Y148.98%
EPS Next 2Y90.18%
EPS Next 3Y57.13%
EPS Next 5Y41.31%
Revenue Next Year16.21%
Revenue Next 2Y10%
Revenue Next 3Y8.05%
Revenue Next 5Y5.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ELIOR. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 7.75, the valuation of ELIOR can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELIOR indicates a rather cheap valuation: ELIOR is cheaper than 88.00% of the companies listed in the same industry.
ELIOR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE N/A
Fwd PE 7.75

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELIOR is valued a bit cheaper than 78.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ELIOR is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.08
EV/EBITDA 6.59

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELIOR's earnings are expected to grow with 57.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.18%
EPS Next 3Y57.13%

0

5. Dividend

5.1 Amount

No dividends for ELIOR!.
Industry RankSector Rank
Dividend Yield N/A

ELIOR GROUP

EPA:ELIOR (12/20/2024, 7:00:00 PM)

2.734

+0.05 (+1.79%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-20 2024-11-20/bmo
Earnings (Next)N/A N/A
Inst Owners20.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap693.37M
Analysts72
Price Target3.63 (32.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.03%
PT rev (3m)2.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.75
P/S 0.12
P/FCF 6.08
P/OCF 3.33
P/B 0.84
P/tB N/A
EV/EBITDA 6.59
EPS(TTM)-0.28
EYN/A
EPS(NY)0.35
Fwd EY12.9%
FCF(TTM)0.45
FCFY16.44%
OCF(TTM)0.82
OCFY30%
SpS23.14
BVpS3.26
TBVpS-4.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.81%
ROE -8.34%
ROCE 4.32%
ROIC 3.11%
ROICexc 3.23%
ROICexgc 42.88%
OM 1.55%
PM (TTM) N/A
GM 70.72%
FCFM 1.94%
ROA(3y)-6.07%
ROA(5y)-4.91%
ROE(3y)-25.24%
ROE(5y)-20.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.58%
ROICexc growth 3YN/A
ROICexc growth 5Y-16.06%
OM growth 3YN/A
OM growth 5Y-24.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.05%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 11.04
Debt/EBITDA 4.13
Cap/Depr 51.09%
Cap/Sales 1.6%
Interest Coverage 1.02
Cash Conversion 75.64%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.66
Altman-Z 1.61
F-Score6
WACC6.01%
ROIC/WACC0.52
Cap/Depr(3y)39.72%
Cap/Depr(5y)50.32%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.14%
EPS Next Y148.98%
EPS Next 2Y90.18%
EPS Next 3Y57.13%
EPS Next 5Y41.31%
Revenue 1Y (TTM)25.12%
Revenue growth 3Y9.6%
Revenue growth 5Y1.34%
Sales Q2Q%26.03%
Revenue Next Year16.21%
Revenue Next 2Y10%
Revenue Next 3Y8.05%
Revenue Next 5Y5.22%
EBIT growth 1Y555%
EBIT growth 3YN/A
EBIT growth 5Y-23.86%
EBIT Next Year624.9%
EBIT Next 3Y111.04%
EBIT Next 5Y62.34%
FCF growth 1Y195%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y533.33%
OCF growth 3YN/A
OCF growth 5Y-36.25%